EG-1962: Completed Phase I/II enrollment

Edge completed enrollment of 72 patients who had a subarachnoid hemorrhage (SAH) in the open-label, dose-escalation, international Phase I/II NEWTON trial comparing a single dose of 100, 200, 400, 600...